-
1
-
-
0026058540
-
Inhibition of the replication of hepatitis B virus in vitro by 2′ 3′-dideoxy-3′-thiacytidine and related analogues
-
Doong S L, Tsai C H, Schinazi R F, Liotta D C, Cheng Y C. Inhibition of the replication of hepatitis B virus in vitro by 2′, 3′-dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci USA 1991; 88: 8495-9.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 8495-8499
-
-
Doong, S.L.1
Tsai, C.H.2
Schinazi, R.F.3
Liotta, D.C.4
Cheng, Y.C.5
-
2
-
-
0028894411
-
Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients
-
Benhamou Y, Dohin E, Lunel-Fabiani F, Poynard T, Huraox J M, Katlama C, et al. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Lancet 1995; 345: 396-7.
-
(1995)
Lancet
, vol.345
, pp. 396-397
-
-
Benhamou, Y.1
Dohin, E.2
Lunel-Fabiani, F.3
Poynard, T.4
Huraox, J.M.5
Katlama, C.6
-
3
-
-
0037221907
-
Histological outcome during long-term lamivudine therapy
-
Dienstag J L, Goldin R D, Heathcote E J, Hann H W, Woessner M, Stephenson S L, et al. Histological outcome during long-term lamivudine therapy. Gastroenterology 2003; 124: 105-17.
-
(2003)
Gastroenterology
, vol.124
, pp. 105-117
-
-
Dienstag, J.L.1
Goldin, R.D.2
Heathcote, E.J.3
Hann, H.W.4
Woessner, M.5
Stephenson, S.L.6
-
4
-
-
0029591574
-
A preliminary trial of lamivudine for chronic hepatitis B infection
-
Dienstag J L, Perrillo R P, Schiff E R, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657-61.
-
(1995)
N Engl J Med
, vol.333
, pp. 1657-1661
-
-
Dienstag, J.L.1
Perrillo, R.P.2
Schiff, E.R.3
Bartholomew, M.4
Vicary, C.5
Rubin, M.6
-
5
-
-
0032499913
-
A one-year trial of lamivudine for chronic hepatitis B
-
Asia Hepatitis Lamivudine Study Group
-
Lai C L, Chien R N, Leung N W, Chang T T, Guan R, Tai D I, et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998; 339: 61-8.
-
(1998)
N Engl J Med
, vol.339
, pp. 61-68
-
-
Lai, C.L.1
Chien, R.N.2
Leung, N.W.3
Chang, T.T.4
Guan, R.5
Tai, D.I.6
-
6
-
-
19544391413
-
Lamivudine for patients with chronic hepatitis B and advanced liver disease
-
Liaw Y F, Sung J J, Chow W C, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004; 351: 1521-31.
-
(2004)
N Engl J Med
, vol.351
, pp. 1521-1531
-
-
Liaw, Y.F.1
Sung, J.J.2
Chow, W.C.3
-
7
-
-
23044471083
-
Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2,795 patients
-
Matsumoto A, Tanaka E, Rokuhara A, et al. Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2,795 patients. Hepatol Res 2005; 32: 173-84.
-
(2005)
Hepatol Res
, vol.32
, pp. 173-184
-
-
Matsumoto, A.1
Tanaka, E.2
Rokuhara, A.3
-
8
-
-
0029815110
-
Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine
-
Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24: 711-3.
-
(1996)
Hepatology
, vol.24
, pp. 711-713
-
-
Ling, R.1
Mutimer, D.2
Ahmed, M.3
-
9
-
-
10744225554
-
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
-
Lok A S, Lai C L, Leung N, Yao G B, Cui Z Y, Schiff E R, et al. Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology 2003; 125: 1714-22.
-
(2003)
Gastroenterology
, vol.125
, pp. 1714-1722
-
-
Lok, A.S.1
Lai, C.L.2
Leung, N.3
Yao, G.B.4
Cui, Z.Y.5
Schiff, E.R.6
-
10
-
-
0029817898
-
Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo
-
Tipples G A, Ma M M, Fischer K P, Bain V G, Kneteman N M, Tyrrell D L. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24: 714-7.
-
(1996)
Hepatology
, vol.24
, pp. 714-717
-
-
Tipples, G.A.1
Ma, M.M.2
Fischer, K.P.3
Bain, V.G.4
Kneteman, N.M.5
Tyrrell, D.L.6
-
11
-
-
0032783679
-
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
-
Liaw Y F, Chien R N, Yeh C T, Tsai S L, Chu C M. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology 1999; 30: 567-72.
-
(1999)
Hepatology
, vol.30
, pp. 567-572
-
-
Liaw, Y.F.1
Chien, R.N.2
Yeh, C.T.3
Tsai, S.L.4
Chu, C.M.5
-
12
-
-
0042743964
-
Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan
-
Suzuki F, Tsubota A, Arase Y, Suzuki Y S, Akuta N, Hosaka T, et al. Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan. Intervirology 2003; 46: 182-9.
-
(2003)
Intervirology
, vol.46
, pp. 182-189
-
-
Suzuki, F.1
Tsubota, A.2
Arase, Y.3
Suzuki, Y.S.4
Akuta, N.5
Hosaka, T.6
-
13
-
-
0035212206
-
Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy
-
Zollner B, Schafer P, Feucht H H, Schroter M, Petersen J, Laufs R. Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy. J Med Virol 2001; 65: 659-63.
-
(2001)
J Med Virol
, vol.65
, pp. 659-663
-
-
Zollner, B.1
Schafer, P.2
Feucht, H.H.3
Schroter, M.4
Petersen, J.5
Laufs, R.6
-
14
-
-
0036159549
-
Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load
-
Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Klyosawa K, et al. Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol 2002; 40: 439-45.
-
(2002)
J Clin Microbiol
, vol.40
, pp. 439-445
-
-
Kimura, T.1
Rokuhara, A.2
Sakamoto, Y.3
Yagi, S.4
Tanaka, E.5
Klyosawa, K.6
-
15
-
-
0038045168
-
Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment
-
Rokuhara A, Tanaka E, Matsumoto A, Kimura T, Yamaura T, Orii K, et al. Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment. J Viral Hepatol 2003; 10: 324-30.
-
(2003)
J Viral Hepatol
, vol.10
, pp. 324-330
-
-
Rokuhara, A.1
Tanaka, E.2
Matsumoto, A.3
Kimura, T.4
Yamaura, T.5
Orii, K.6
-
16
-
-
0023926648
-
Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein
-
Bruss V, Gerlich W H. Formation of transmembraneous hepatitis B e-antige0n by cotranslational in vitro processing of the viral precore protein. Virology 1988; 163: 268-75.
-
(1988)
Virology
, vol.163
, pp. 268-275
-
-
Bruss, V.1
Gerlich, W.H.2
-
17
-
-
0023943302
-
Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: After signal peptide cleavage translocation can be aborted and the product released into the cytoplasm
-
Garcia P D, Ou J H, Rutter W J, Walter P. Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: After signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J Cell Biol 1988; 106: 1093-104.
-
(1988)
J Cell Biol
, vol.106
, pp. 1093-1094
-
-
Garcia, P.D.1
Ou, J.H.2
Rutter, W.J.3
Walter, P.4
-
18
-
-
0030707941
-
Hepatitis B virus infection
-
Lee W M. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.
-
(1997)
N Engl J Med
, vol.337
, pp. 1733-1745
-
-
Lee, W.M.1
-
19
-
-
0033045135
-
Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns
-
Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Mukaide M, et al. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 1999; 450: 66-71.
-
(1999)
FEBS Lett
, vol.450
, pp. 66-71
-
-
Mizokami, M.1
Nakano, T.2
Orito, E.3
Tanaka, Y.4
Sakugawa, H.5
Mukaide, M.6
-
20
-
-
0034056702
-
Development of a new method for detecting a mutation in the gene encoding hepatitis B virus reverse transcriptase active site (YMDD motif)
-
Kobayashi S, Shimada K, Suzuki H, Tanikawa K, Sata M. Development of a new method for detecting a mutation in the gene encoding hepatitis B virus reverse transcriptase active site (YMDD motif). Hepatol Res 2000; 17: 31-42.
-
(2000)
Hepatol Res
, vol.17
, pp. 31-42
-
-
Kobayashi, S.1
Shimada, K.2
Suzuki, H.3
Tanikawa, K.4
Sata, M.5
-
21
-
-
0021075142
-
Experimental transmission of duck hepatitis B virus
-
Mason W S, Halpern M S, England J M, Seal G, Egan J, Coates L, et al. Experimental transmission of duck hepatitis B virus. Virology 1983; 131: 375-84.
-
(1983)
Virology
, vol.131
, pp. 375-384
-
-
Mason, W.S.1
Halpern, M.S.2
England, J.M.3
Seal, G.4
Egan, J.5
Coates, L.6
-
22
-
-
0025334855
-
Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification
-
Summers J, Smith P M, Horwich A L. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 1990; 64: 2819-24.
-
(1990)
J Virol
, vol.64
, pp. 2819-22924
-
-
Summers, J.1
Smith, P.M.2
Horwich, A.L.3
-
23
-
-
0023028191
-
Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells
-
Tuttleman J S, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986; 47: 451-60.
-
(1986)
Cell
, vol.47
, pp. 451-460
-
-
Tuttleman, J.S.1
Pourcel, C.2
Summers, J.3
-
24
-
-
0030776176
-
Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus
-
Moraleda G, Saputelli J, Aldrich C E, Averett D, Condreay L, Mason W S. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol 1997; 71: 9392-9.
-
(1997)
J Virol
, vol.71
, pp. 9392-9399
-
-
Moraleda, G.1
Saputelli, J.2
Aldrich, C.E.3
Averett, D.4
Condreay, L.5
Mason, W.S.6
-
25
-
-
2942532722
-
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
-
Werle-Lapostolle B, Bowden S, Locarnini S, Worsthorn K, Petersen J, Lau G, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004; 126: 1750-8.
-
(2004)
Gastroenterology
, vol.126
, pp. 1750-1758
-
-
Werle-Lapostolle, B.1
Bowden, S.2
Locarnini, S.3
Worsthorn, K.4
Petersen, J.5
Lau, G.6
-
26
-
-
0034749753
-
Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis
-
Zhu Y, Yamamoto T, Cullen J, et al. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol 2001; 75: 311-22.
-
(2001)
J Virol
, vol.75
, pp. 311-322
-
-
Zhu, Y.1
Yamamoto, T.2
Cullen, J.3
-
27
-
-
0033802362
-
Long-term therapy of chronic hepatitis B with lamivudine
-
Lau D T, Khokhar M F, Doo E, Ghany M G, Herion D, Park Y, et al. Long-term therapy of chronic hepatitis B with lamivudine. Hepatology 2000; 32: 828-34.
-
(2000)
Hepatology
, vol.32
, pp. 828-834
-
-
Lau, D.T.1
Khokhar, M.F.2
Doo, E.3
Ghany, M.G.4
Herion, D.5
Park, Y.6
-
28
-
-
0034802516
-
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy
-
Yuen M F, Sablon E, Hui C K, Yuan H J, Decraemer H, Lai C L. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology 2001; 34: 785-91.
-
(2001)
Hepatology
, vol.34
, pp. 785-791
-
-
Yuen, M.F.1
Sablon, E.2
Hui, C.K.3
Yuan, H.J.4
Decraemer, H.5
Lai, C.L.6
-
29
-
-
0037353088
-
Response predictors and results of a long-term treatment with lamivudine in patients with chronic hepatitis B
-
Mihm U, Sarrazin C, Herrmann E, Teuber G, von Wagner M, Kronea berger B, et al. Response predictors and results of a long-term treatment with lamivudine in patients with chronic hepatitis B. Z Gastroenterol 2003; 41: 249-54.
-
(2003)
Z Gastroenterol
, vol.41
, pp. 249-254
-
-
Mihm, U.1
Sarrazin, C.2
Herrmann, E.3
Teuber, G.4
von Wagner, M.5
Kronea Berger, B.6
|